Home
Storia in 1 fonti
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the countrys PDP programme, providing access to around 70% of public-sector demand.
Raccontata da
economictimes.indiatimes.com
Timeline cronologica
- ·
Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drug
In a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its collaboration with Bahiafarma and Bionovis.…
- ·
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the…
- ·
Biocon shares: Active Pine may divest up to 1% equity worth Rs 638 crore via block deal
Active Pine is likely to sell up to 1.66 crore Biocon shares, worth Rs 638 crore, through a block deal at Rs 385 per share. The development comes alongside Biocons Brazil…